MedPath

SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

Phase 3
Completed
Conditions
Advanced Stage Parkinson's Disease
Interventions
Drug: Placebo Comparator
Registration Number
NCT00406588
Lead Sponsor
Solvay Pharmaceuticals
Brief Summary

This study is a multicenter, randomized, double blind, parallel group study of 3 months' treatment with SLV308 administered as a monotherapy in patients with advance stage PD. An open label safety extension to this study is planned as a separate protocol for patients who are willing and eligible to participate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
295
Inclusion Criteria
  • Diagnosis of idiopathic Parkinson's Disease,
  • advance stage of disease,
  • Modified Hoehn & Yahr stage II-IV,
  • presence of a recognizable 'on' and 'off' state (motor fluctuations) and stable treatment with levodopa for at least 28 days prior to randomization
Exclusion Criteria
  • 'on-off' phenomena or 'yo-yoing' and/or an abrupt unpredictable loss of efficacy unrelated to the timing of L-DOPA administration,
  • Prevalent expression of troublesome dyskinesias during 'on' time at waking hours,
  • Diagnosis is unclear or a suspicion of other parkinsonian syndromes exists,
  • Previous surgery for the treatment of PD

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Levodopa (Pardoprunox)-
2Placebo Comparator-
Primary Outcome Measures
NameTimeMethod
Change from baseline to end of the maintenance period or at the early termination visit in 'off'-time as recorded in patients' home diaries.12 weeks
Secondary Outcome Measures
NameTimeMethod
Increase of 'on'-time, change from baseline in the total score of the UPDRS part 2+3, and PDQ-3912 weeks

Trial Locations

Locations (87)

Site 220

🇺🇸

LaJolla, California, United States

Site 223

🇺🇸

Birmingham, Alabama, United States

Site 211

🇺🇸

San Francisco, California, United States

Site 214

🇺🇸

Fort Lauderdale, Florida, United States

Site 218

🇺🇸

Gainsville, Florida, United States

Site 213

🇺🇸

Tampa, Florida, United States

Site 212

🇺🇸

East Lansing, Michigan, United States

Site 219

🇺🇸

Augusta, Georgia, United States

Site 221

🇺🇸

Chicago, Illinois, United States

Site 224

🇺🇸

Lexington, Kentucky, United States

Site 216

🇺🇸

Kansas City, Kansas, United States

Site 217

🇺🇸

St. Louis, Missouri, United States

Site 222

🇺🇸

Durham, North Carolina, United States

Site 210

🇺🇸

Toledo, Ohio, United States

Site 215

🇺🇸

Houston, Texas, United States

Site 103

🇦🇷

Buenos Aires, Argentina

Site 102

🇦🇷

Buenos Aires, Argentina

Site 101

🇦🇷

Buenos Aires, Argentina

Site 100

🇦🇷

Buenos Aires, Argentina

Site 107

🇦🇷

Buenos Aires, Argentina

Site 106

🇦🇷

Buenos Aires, Argentina

Site 109

🇦🇷

Buenos Aires, Argentina

Site 104

🇦🇷

Mar del Plata, Argentina

Site 105

🇦🇷

Cordoba, Argentina

Site 108

🇦🇷

Santa Fe, Argentina

Site 114

🇧🇷

Alto da Gloria, Brazil

Site 113

🇧🇷

Belo Horizonte, Brazil

Site 112

🇧🇷

Campinas, Brazil

Site 116

🇧🇷

Marilia, Brazil

Site 111

🇧🇷

Porto Alegre, Brazil

Site 117

🇧🇷

Ribeirao Preto, Brazil

Site 118

🇧🇷

Porto Alegre, Brazil

Site 119

🇧🇷

Salvador, Brazil

Site 115

🇧🇷

Sao Paulo, Brazil

Site 110

🇧🇷

Sao Paulo, Brazil

Site 125

🇧🇷

Sao Paulo, Brazil

Site 123

🇧🇬

Plovdiv, Bulgaria

Site 120

🇧🇬

Sofia, Bulgaria

Site 121

🇧🇬

Sofia, Bulgaria

Site 122

🇧🇬

Sofia, Bulgaria

Site 133

🇨🇦

Halifax, Canada

Site 124

🇧🇬

Sofia, Bulgaria

Site 136

🇨🇦

Calgary, Canada

Site 137

🇨🇦

Greenfield Park, Canada

Site 132

🇨🇦

Markham, Canada

Site 134

🇨🇦

Ottawa, Canada

Site 139

🇨🇦

Toronto, Canada

Site 138

🇨🇦

Peterborough, Canada

Site 130

🇨🇦

Montreal, Canada

Site 135

🇨🇦

Sainte-Anne, Canada

Site 140

🇨🇱

Santiago de Chile, Chile

Site 131

🇨🇦

Windsor, Canada

Site 141

🇨🇱

Santiago de Chile, Chile

Site 143

🇨🇱

Santiago de Chile, Chile

Site 151

🇨🇴

Bogota, Colombia

Site 154

🇨🇴

Bogota, Colombia

Site 152

🇨🇴

Bogota, Colombia

Site 150

🇨🇴

Medellin, Colombia

Site 184

🇵🇪

Bellavista Callao, Peru

Site 193

🇷🇺

Kazan, Russian Federation

Site 190

🇷🇺

Moscow, Russian Federation

Site 194

🇷🇺

Moscow, Russian Federation

Site 191

🇷🇺

Saint-Petersburg, Russian Federation

Site 197

🇷🇺

Moscow, Russian Federation

Site 198

🇷🇺

Saint Petersburg, Russian Federation

Site 192

🇷🇺

Saint-Petersburg, Russian Federation

Site 204

🇺🇦

Dnepropetrovsk, Ukraine

Site 195

🇷🇺

Saint-Petersburg, Russian Federation

Site 196

🇷🇺

Yaroslavl, Russian Federation

Site 206

🇺🇦

Kharkiv, Ukraine

Site 202

🇺🇦

Kyiv, Ukraine

Site 205

🇺🇦

Lviv, Ukraine

Site 208

🇺🇦

Simferopol, Ukraine

Site 172

🇱🇹

Kaunas, Lithuania

Site 170

🇱🇹

Vilnius, Lithuania

Site 171

🇱🇹

Vilnius, Lithuania

Site 180

🇵🇪

Lima, Peru

Site 181

🇵🇪

Lima, Peru

Site 182

🇵🇪

Lima, Peru

Site 183

🇵🇪

Lima, Peru

Site 207

🇺🇦

Zaporizhya, Ukraine

Site 153

🇨🇴

Bogota, Colombia

Site 142

🇨🇱

Valdivia, Chile

Site 201

🇺🇦

Kyiv, Ukraine

Site 203

🇺🇦

Poltava, Ukraine

Site 200

🇺🇦

Vinnitsa, Ukraine

Site 160

🇱🇻

Riga, Latvia

© Copyright 2025. All Rights Reserved by MedPath